A., Mitchell, E., Poling, J., Gonsai, K
Retatrutide and Cagrilintide: These investigational GLP-1/GIP/glucagon triagonists cannot legally be used in compounding under federal law regardless of shortage status
GLP-2 strengthens the gut lining and boosts mucosal immunity, creating a stable foundation for all other health systems
According to FDA-approved labeling, unopened tirzepatide pens should be refrigerated at 36F to 46F (2C to 8C) and protected from light in their original carton
The dual GLP-1/GIP mechanism provides superior appetite suppression and metabolic effects
The active ingredients in the medications are the same compounds used in the major weight loss clinical trials